"Fees and Charges" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Amounts charged to the patient as payer for health care services.
Below are MeSH descriptors whose meaning is more general than "Fees and Charges".
Below are MeSH descriptors whose meaning is more specific than "Fees and Charges".
This graph shows the total number of publications written about "Fees and Charges" by people in this website by year, and whether "Fees and Charges" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Fees and Charges" by people in Profiles.
Association of Private Equity Acquisition of Physician Practices With Changes in Health Care Spending and Utilization. JAMA Health Forum. 2022 09 02; 3(9):e222886.
Cost Analysis of Liver Acquisition Fees Before and After Acuity Circle Policy Implementation. JAMA Surg. 2021 11 01; 156(11):1051-1057.
Clinician Use of Advance Care Planning Billing Codes among Privately Insured Patients in 2016. J Palliat Med. 2019 11; 22(11):1304-1305.
The Impact of Changes in Medicaid Provider Fees on Provider Participation and Enrollees' Care: a Systematic Literature Review. J Gen Intern Med. 2019 10; 34(10):2200-2209.
The effect of contralateral prophylactic mastectomy on breast-related charges: A 5-year analysis. J Surg Oncol. 2018 Jul; 118(1):212-220.
Post-Discharge Care Duration, Charges, and Outcomes Among Medicare Patients After Primary Total Hip and Knee Arthroplasty. J Bone Joint Surg Am. 2017 Jun 07; 99(11):e55.
The Challenge of Understanding Health Care Costs and Charges. AMA J Ethics. 2015 Nov 01; 17(11):1046-52.
Forecasting unanticipated consequences of "The Sunshine Act": mostly cloudy. J Clin Oncol. 2014 Aug 01; 32(22):2293-5.
Economic burden of renal cell carcinoma in the US: Part II--an updated analysis. Pharmacoeconomics. 2011 Apr; 29(4):331-41.
Saving lives is more important than abstract moral concerns: financial incentives should be used to increase organ donation. Ann Thorac Surg. 2009 Oct; 88(4):1053-61.